T-cell receptor beta variable 12 (TRBV12)

T-cell receptor beta variable 12 (TRBV12) is a family of variable segments (including TRBV12-3, TRBV12-4, and TRBV12-5) that form the antigen-binding region of the T-cell receptor (TCR) beta chain [2, 4, 5]. Its primary biological function is to recognize peptide-MHC complexes, which triggers T-cell activation and the subsequent adaptive immune response [3, 12]. In T-cell malignancies, such as T-cell lymphoma and T-cell acute lymphoblastic leukemia (T-ALL), a single malignant clone expands and expresses a unique TRBV family, making TRBV12 a highly specific therapeutic target [14, 16, 23]. By targeting the specific TRBV family expressed by the cancer, therapies can selectively deplete the malignant cells while sparing the majority of the healthy T-cell repertoire, which typically expresses a diverse range of other TRBV families [14, 27, 31]. Current therapeutic strategies under development include TRBV12-specific bispecific antibodies (e.g., TRBV12 x CD3), CAR-T cells, and antibody-drug conjugates (ADCs) [22, 23, 26, 33]. These agents aim to provide a precision medicine approach to T-cell cancers, minimizing the severe immunosuppression associated with pan-T-cell targeting agents [14, 15, 32].

Other names

TCRBV12TCR V-beta 12TRBV12-3TRBV12-4TRBV12-5TCRBV8S1TCRBV8S3TCRBV12S3TCRBV12S5T-cell receptor beta variable 12-3T-cell receptor beta variable 12-4T-cell receptor beta variable 12-5V-beta 12Vβ12

Selective depletion of T-cell clones expressing the TRBV12 variable region via T-cell mediated cytotoxicity, direct lysis, or cytotoxic payload delivery.